DETROIT, July 6 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has started shipping azelastine ophthalmic solution, 0.05%. This ...
Alembic Pharmaceuticals has received the Food and Drug Administration’s approval for azelastine hydrochloride ophthalmic solution, 0.05%. The product is the generic of Mylan’s Optivar.
MUMBAI, June 22 (Reuters) - Indian drugmaker Sun Pharmaceuticals has received approval from the U.S. Food and Drug Administration to launch a generic version of Optivar, used to treat itching of the ...
Alembic is introducing generic Optivar ophthalmic solution, in a dosage strength of 0.05%. The product is indicated for the treatment of itching of the eye associated with allergic conjunctivitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results